Predictive Models for Identifying Adult Patients at High Risk of Developing Opioid-Related Harms: a Systematic Review
Malede Berihun Yismaw (), 
Gregory M. Peterson, 
Belayneh Kefale and 
Woldesellassie M. Bezabhe
Additional contact information 
Malede Berihun Yismaw: Bahir Dar University
Gregory M. Peterson: University of Tasmania
Belayneh Kefale: Bahir Dar University
Woldesellassie M. Bezabhe: University of Tasmania
Drug Safety, 2025, vol. 48, issue 11, No 1, 1177-1187
Abstract:
Abstract Introduction Opioids are the most frequently prescribed medications for managing moderate-to-severe pain and are associated with significant potential for harm. Several models have been developed to predict opioid-related harms (ORHs). This study aimed to describe and evaluate the methodological quality of predictive models for identifying patients at high risk of ORHs. Methods Using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline, we reviewed published studies on developing or validating models for predicting ORHs, identified through a literature search of Scopus, PubMed, Embase, and Google Scholar. The quality of studies was assessed using the Prediction model Risk Of Bias ASsessment Tool (PROBAST). The models were assessed by area under the curve (AUC) or c-statistic, sensitivity, specificity, accuracy, and positive or negative predictive value. The study protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO; CRD42024540456). Results We included 36 studies involving participants aged 18 years or older. The frequently modeled ORHs were opioid use disorder (12 studies), opioid overdose (8 studies), opioid-induced respiratory depression (6 studies), and adverse drug events (4 studies). In total, 16 studies (44.4%) developed and validated tools. Most studies measured predictive ability using AUC (31, 86.1%), and some only reported sensitivity (14, 38.9%), specificity (11, 30.6%), or accuracy (4, 11.1%). Of the 31 studies that reported AUC values, 29 (93.5%) had moderate-to-high predictive ability (AUC > 0.70). History of opioid use (66.7%), age (58.3%), comorbidities (41.7%), sex (41.7%), and drug abuse and psychiatric problems (36.1%) were typical factors used in developing models. Conclusions The included predictive models showed moderate-to-high discriminative ability for screening patients at risk of ORHs. However, future studies should refine and validate them in various settings before considering the translation into clinical practice.
Date: 2025
References: Add references at CitEc 
Citations: 
Downloads: (external link)
http://link.springer.com/10.1007/s40264-025-01563-4 Abstract (text/html)
Access to the full text of the articles in this series is restricted.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX 
RIS (EndNote, ProCite, RefMan) 
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:spr:drugsa:v:48:y:2025:i:11:d:10.1007_s40264-025-01563-4
Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/40264
DOI: 10.1007/s40264-025-01563-4
Access Statistics for this article
Drug Safety is currently edited by Nitin Joshi
More articles in Drug Safety  from  Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().